Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 30 Oct 2023 23:29 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA – Subsequent Offering Cancelled | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Oct 2023 16:15 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 25 Oct 2023 17:22 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 25 Oct 2023 15:32 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 25 Oct 2023 14:33 CEST |
NYKODE THERAPEUTICS ASA | Disclosure of shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 25 Oct 2023 08:15 CEST |
NYKODE THERAPEUTICS ASA | Disclosure of shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 25 Oct 2023 02:05 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA – Share Lending by Closely Associated Parties of a Primary Insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 25 Oct 2023 01:54 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA – Key Information Regarding Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Oct 2023 01:50 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA - Private Placement Completed | 20103010 Biotechnology | Inside information |
| 24 Oct 2023 16:30 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA - Contemplated Private Placement | 20103010 Biotechnology | Inside information |
| 23 Oct 2023 20:58 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Update on process with the Norwegian Tax Authorities | 20103010 Biotechnology | Non-regulatory press releases |
| 12 Oct 2023 16:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – presentation from the mRNA Cancer Vaccines Summit 2023 in Boston | 20103010 Biotechnology | Non-regulatory press releases |
| 09 Oct 2023 06:45 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics to Present at the mRNA Cancer Vaccines Summit 2023 in Boston | 20103010 Biotechnology | Non-regulatory press releases |
| 29 Sep 2023 07:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Initiates Phase 1/2a Trial of VB10.16 in First Line HPV16-Positive Head and Neck Cancer | 20103010 Biotechnology | Non-regulatory press releases |
| 27 Sep 2023 14:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - presentation from Capital Markets Day in Oslo | 20103010 Biotechnology | Non-regulatory press releases |
| 25 Sep 2023 08:30 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Invitation to Capital Markets Day in Oslo on September 27, 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Sep 2023 16:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Announces Advances in Clinical Pipeline and Research | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Sep 2023 10:36 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 07 Sep 2023 16:34 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – Invitation to Capital Markets Day in New York on September 20, 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 05 Sep 2023 07:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Announces FDA Approval of IND for VB-C-04, a Trial of VB10.16 in HPV16-Positive Cervical Cancer | 20103010 Biotechnology | Non-regulatory press releases |
| 23 Aug 2023 06:45 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Quarterly report Q2 2023 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 17 Aug 2023 08:30 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics to announce financial results for the second quarter 2023 and host webcast presentation on August 23, 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 07 Jul 2023 17:01 CEST |
NYKODE THERAPEUTICS ASA | Grant of share options | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 03 Jul 2023 20:54 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics – updated company presentation July 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 01 Jun 2023 06:45 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Announces Expansion of Clinical Collaboration with Roche to Evaluate VB10.16 in Combination with anti-PD-L1 in the next trial in Advanced Cervical Cancer | 20103010 Biotechnology | Non-regulatory press releases |
| 30 May 2023 18:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics to Present at Jefferies Healthcare Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 26 May 2023 16:46 CEST |
NYKODE THERAPEUTICS ASA | Grant of share options | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 12 May 2023 07:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Quarterly report Q1 2023 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 11 May 2023 11:10 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA - Minutes of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 May 2023 17:25 CEST |
NYKODE THERAPEUTICS ASA | Disclosure of voting rights at AGM | 20103010 Biotechnology | Major shareholding notifications |
| 08 May 2023 19:40 CEST |
NYKODE THERAPEUTICS ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 May 2023 19:40 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics to announce financial results for the first quarter 2023 and host webcast presentation on May 12, 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Apr 2023 07:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA - Notice of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Apr 2023 08:00 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Annual Report 2022 | 20103010 Biotechnology | Annual financial and audit Reports |
| 18 Apr 2023 16:44 CEST |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics announces positive final results from its Phase 2 trial of VB10.16 in combination with PD-L1 inhibitor atezolizumab in advanced cervical cancer | 20103010 Biotechnology | Inside information |
| 28 Feb 2023 07:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Quarterly report 4Q 2022 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 22 Feb 2023 13:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics to announce financial results for the fourth quarter 2022 and host webcast presentation on February 28, 2023 | 20103010 Biotechnology | Non-regulatory press releases |
| 13 Feb 2023 08:11 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics ASA – Flaggemelding Jan Haudemann-Andersen | 20103010 Biotechnology | Flagging |
| 10 Feb 2023 06:45 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics Announces Collaboration with The GOG Foundation, Inc. to Conduct the VB-C-04 Trial in Advanced Cervical Cancer | 20103010 Biotechnology | Non-regulatory press releases |
| 07 Feb 2023 13:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics to Present at SVB Securities Global Biopharma Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 01 Feb 2023 13:31 CET |
NYKODE THERAPEUTICS ASA | Registration of new share capital | 20103010 Biotechnology | Total number of voting rights and capital |
| 25 Jan 2023 18:45 CET |
NYKODE THERAPEUTICS ASA | Exercise of warrants and related transactions by primary insiders | - | Mandatory notification of trade primary insiders |
| 09 Jan 2023 17:45 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics - Presentation at the 41st Annual J.P. Morgan Healthcare Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Dec 2022 09:25 CET |
NYKODE THERAPEUTICS ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Dec 2022 11:00 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Dec 2022 12:43 CET |
NYKODE THERAPEUTICS ASA | Share capital increase from exercise of warrants | 20103010 Biotechnology | Total number of voting rights and capital |
| 20 Dec 2022 16:11 CET |
NYKODE THERAPEUTICS ASA | Registration of new share capital | 20103010 Biotechnology | Total number of voting rights and capital |
| 20 Dec 2022 06:45 CET |
NYKODE THERAPEUTICS ASA | Nykode announces expanded clinical development plan for its lead cancer vaccine VB10.16 in HPV16-positive cancers | 20103010 Biotechnology | Non-regulatory press releases |
| 19 Dec 2022 06:45 CET |
NYKODE THERAPEUTICS ASA | Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership | 20103010 Biotechnology | Non-regulatory press releases |
| 18 Dec 2022 22:45 CET |
NYKODE THERAPEUTICS ASA | Exercise of warrants by primary insider, transactions by a primary insider and a close associate, and disclosure of large shareholding | 20103010 Biotechnology | Mandatory notification of trade primary insiders |